Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Gabapentin MeSH Descriptor Data 2025


MeSH Heading
Gabapentin
Tree Number(s)
D02.092.521
D02.241.081.114.500.350.300
D02.241.223.268.469
D02.455.426.392.368.367.218.500
D12.125.190.350.225
Unique ID
D000077206
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077206
Scope Note
A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
Entry Term(s)
1-(Aminomethyl)cyclohexaneacetic Acid
Apo-Gabapentin
Convalis
Gabapentin Hexal
Gabapentin Stada
Gabapentin-Ratiopharm
Neurontin
Novo-Gabapentin
PMS-Gabapentin
Pharm Action
Analgesics
Anticonvulsants
Anti-Anxiety Agents
Excitatory Amino Acid Antagonists
Antimanic Agents
Registry Numbers
6CW7F3G59X
0
Public MeSH Note
2019; GABAPENTIN was indexed under AMINES, CYCLOHEXANECARBOXYLIC ACIDS, and GAMMA-AMINOBUTYRIC ACID 2005-2018; and under ACETIC ACIDS 1984-2004
History Note
2019 (1984)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/01/16
Gabapentin Preferred
Apo-Gabapentin Narrower
Gabapentin Hexal Narrower
Gabapentin Stada Narrower
Gabapentin-Ratiopharm Narrower
Novo-Gabapentin Narrower
PMS-Gabapentin Narrower
Neurontin Narrower
Convalis Narrower
page delivered in 0.191s